BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17210976)

  • 1. Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection.
    Mantegani P; Piana F; Codecasa L; Galli L; Scarpellini P; Lazzarin A; Cirillo D; Fortis C
    Clin Med Res; 2006 Dec; 4(4):266-72. PubMed ID: 17210976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
    J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay.
    Zhang M; Wang H; Liao M; Chen X; Graner M; Zhu X; Zhang J; Yang Q; Lu H; Zhou B; Chen X
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1556-63. PubMed ID: 21144240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a commercial and an in-house T cell-based assay for the diagnosis of Mycobacterium tuberculosis infection.
    Mantegani P; Piana F; Galli L; Scarpellini P; Codecasa L; Lazzarin A; Cirillo D; Fortis C
    New Microbiol; 2007 Jul; 30(3):291-4. PubMed ID: 17802912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.
    Jiang W; Shao L; Zhang Y; Zhang S; Meng C; Xu Y; Huang L; Wang Y; Wang Y; Weng X; Zhang W
    BMC Immunol; 2009 May; 10():31. PubMed ID: 19476627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELISPOT-IFN-gamma assay instead of tuberculin skin test for detecting latent Mycobacterium tuberculosis infection in rheumatic patients candidate to anti-TNF-alpha treatment.
    Girlanda S; Mantegani P; Baldissera E; Aiello P; Ratti M; Sabbadini MG; Fortis C
    Clin Rheumatol; 2010 Oct; 29(10):1135-41. PubMed ID: 20645117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients.
    Winthrop KL; Nyendak M; Calvet H; Oh P; Lo M; Swarbrick G; Johnson C; Lewinsohn DA; Lewinsohn DM; Mazurek GH
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1357-63. PubMed ID: 18550653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-SPOT.TB: an in vitro diagnostic assay measuring T-cell reaction to Mycobacterium tuberculosis-specific antigens.
    Wagstaff AJ; Zellweger JP
    Mol Diagn Ther; 2006; 10(1):57-63; discussion 64-5. PubMed ID: 16646578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia.
    Adetifa IM; Lugos MD; Hammond A; Jeffries D; Donkor S; Adegbola RA; Hill PC
    BMC Infect Dis; 2007 Oct; 7():122. PubMed ID: 17961228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
    Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
    BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy.
    Xie X; Chen JW; Li F; Tian J; Gao JS; Zhang D
    Clin Exp Med; 2011 Sep; 11(3):155-61. PubMed ID: 21161670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.
    Hill PC; Brookes RH; Fox A; Jackson-Sillah D; Jeffries DJ; Lugos MD; Donkor SA; Adetifa IM; de Jong BC; Aiken AM; Adegbola RA; McAdam KP
    PLoS Med; 2007 Jun; 4(6):e192. PubMed ID: 17564487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of an inverse association between tuberculosis infection and atopy: by T-cell-based immune assay (RD1-ELISpot).
    Soysal A; Bahçeciler N; Barlan I; Bakir M
    Pediatr Allergy Immunol; 2008 Dec; 19(8):709-15. PubMed ID: 18266833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test.
    Lee SS; Chou KJ; Su IJ; Chen YS; Fang HC; Huang TS; Tsai HC; Wann SR; Lin HH; Liu YC
    Infection; 2009 Apr; 37(2):96-102. PubMed ID: 19139810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
    Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
    J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assay.
    Chen X; Yang Q; Zhang M; Graner M; Zhu X; Larmonier N; Liao M; Yu W; Deng Q; Zhou B
    Clin Vaccine Immunol; 2009 Jun; 16(6):879-84. PubMed ID: 19339489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.
    Simsek H; Alpar S; Ucar N; Aksu F; Ceyhan I; Gözalan A; Cesur S; Ertek M
    Jpn J Infect Dis; 2010 Mar; 63(2):99-102. PubMed ID: 20332570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country.
    Kang YA; Lee HW; Yoon HI; Cho B; Han SK; Shim YS; Yim JJ
    JAMA; 2005 Jun; 293(22):2756-61. PubMed ID: 15941805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.